CompoAtlas

Neoflex

Food supplement declared in France, declaration No 2023-11-457, decision dated 9 November 2023

Neoflex is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
Laboratoires Surveal
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
2 gélules par jour
Directions for use
1 à 2 gélules par jour
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Problèmes de foie, Sous anticoagulants, Ulcère (estomac ou duodenum), Enfants (de moins de 6 ans), Enfants (de moins de 10 ans)

Declaration 305073, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Curcuma longa L.RhizomeExtrait sec hydroalcoolique300 mg
Harpagophytum procumbensRacineExtrait sec hydroalcoolique100 mg

Other active ingredients

NamePer day
Phospholipidesnot declared

Additives

E460, E551, E464, E470b

Other ingredients

amidon de maïs

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2023. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

Label warnings

Ne pas utiliser en cas d'ulcère gastrique ou duodénal ou de calcul biliaire, de traitements anticancéreux ou immunosuppresseurs.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line